bit.bio is an award-winning human synthetic biology company - our mission: coding cells for novel cures. We have developed an end-to-end platform for the creation of any human cell type. With our cutting-edge and patent-protected opti-ox precision cell programming technology, we can deterministica...See more
Headquarter United Kingdom of Great Britain and Northern Ireland |
Countries of operation United Kingdom of Great Britain and Northern Ireland |
Year founded 2016 (8 years) |
Funding status Series B |
Company type MNC / Large Enterprise |